Tapayan, Wishney A.
HRN: 21-54-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2022
CEFUROXIME 750MG (VIAL)
07/23/2022
07/24/2022
IV
750mg
Q8
S/P LTCS
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Non-compliant To Guidelines